» Authors » J-Sebastian Muehlboeck

J-Sebastian Muehlboeck

Explore the profile of J-Sebastian Muehlboeck including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 981
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inguanzo A, Mohanty R, Poulakis K, Ferreira D, Segura B, Albrecht F, et al.
NPJ Parkinsons Dis . 2024 Aug; 10(1):159. PMID: 39152153
Parkinson's disease (PD) is clinically heterogeneous, which suggests the existence of subtypes; however, there has been no consensus regarding their characteristics. This study included 633 PD individuals across distinct cohorts:...
2.
Poulakis K, Pereira J, Muehlboeck J, Wahlund L, Smedby O, Volpe G, et al.
Nat Commun . 2024 Jul; 15(1):5784. PMID: 38987238
No abstract available.
3.
Badji A, Cedres N, Muehlboeck J, Khan W, Dhollander T, Barroso J, et al.
Hum Brain Mapp . 2024 Feb; 45(4):e26618. PMID: 38414286
Background: Age-related cognitive decline is linked to changes in the brain, particularly the deterioration of white matter (WM) microstructure that accelerates after the age of 60. WM deterioration is associated...
4.
Dartora C, Marseglia A, Martensson G, Rukh G, Dang J, Muehlboeck J, et al.
Front Aging Neurosci . 2024 Jan; 15:1303036. PMID: 38259636
Introduction: In the last few years, several models trying to calculate the biological brain age have been proposed based on structural magnetic resonance imaging scans (T1-weighted MRIs, T1w) using multivariate...
5.
Rennie A, Ekman U, Wallert J, Muehlboeck J, Eriksdotter M, Wahlund L, et al.
Neurobiol Aging . 2023 Jun; 129:41-49. PMID: 37269645
Subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) are two clinical groups with an increased risk to develop dementia, but they are highly heterogeneous. This study compared three different...
6.
Moridi T, Stawiarz L, McKay K, Ineichen B, Ouellette R, Ferreira D, et al.
Mult Scler J Exp Transl Clin . 2022 Dec; 8(4):20552173221144230. PMID: 36570871
Background: Most previous multiple sclerosis (MS) brain atrophy studies using MS impact scale 29 (MSIS-29) or symbol digit modalities test (SDMT) have been cross-sectional with limited sets of clinical outcomes....
7.
Poulakis K, Pereira J, Muehlboeck J, Wahlund L, Smedby O, Volpe G, et al.
Nat Commun . 2022 Aug; 13(1):4566. PMID: 35931678
Understanding Alzheimer's disease (AD) heterogeneity is important for understanding the underlying pathophysiological mechanisms of AD. However, AD atrophy subtypes may reflect different disease stages or biologically distinct subtypes. Here we...
8.
Mohanty R, Ferreira D, Frerich S, Muehlboeck J, Grothe M, Westman E
Neurology . 2022 May; 99(4):e323-e333. PMID: 35609990
Background And Objectives: To investigate whether antemortem MRI-based atrophy subtypes of Alzheimer disease (AD) differ in neuropathologic features and comorbid non-AD pathologies at postmortem. Methods: From the Alzheimer's Disease Neuroimaging...
9.
Cedres N, Diaz-Galvan P, Diaz-Flores L, Muehlboeck J, Molina Y, Barroso J, et al.
Aging (Albany NY) . 2021 Aug; 13(16):19963-19977. PMID: 34433132
Aims: To investigate the interplay between gray matter (GM) and white matter (WM) neurodegeneration in subjective cognitive decline (SCD), including thickness across the whole cortical mantle, hippocampal volume, and integrity...
10.
Mohanty R, Gonzalez-Burgos L, Diaz-Flores L, Muehlboeck J, Barroso J, Ferreira D, et al.
Front Aging Neurosci . 2021 Jul; 13:644611. PMID: 34290598
Neural compensatory mechanisms associated with broad cognitive abilities have been studied. However, those associated with specific cognitive subdomains (e.g., verbal fluency) remain to be investigated in healthy aging. Here, we...